|
| Status |
Public on May 21, 2018 |
| Title |
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
29866822 |
| |
| Submission date |
Mar 09, 2017 |
| Last update date |
Jul 25, 2021 |
| Contact name |
Matthew Hemming |
| E-mail(s) |
matthew.hemming@umassmemorial.org
|
| Organization name |
UMass Medical School
|
| Street address |
364 Plantation Street
|
| City |
Worcester |
| State/province |
MA |
| ZIP/Postal code |
01605 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
| Samples (74)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE95861 |
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome |
| GSE95862 |
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome |
| GSE95863 |
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome |
|
| Relations |
| BioProject |
PRJNA378612 |
Less...
More...